News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
143,395 Results
Type
Article (10026)
Company Profile (7)
Press Release (133362)
Section
Business (35299)
Career Advice (171)
Deals (5117)
Drug Delivery (7)
Drug Development (17317)
Employer Resources (11)
FDA (4840)
Job Trends (3114)
News (62880)
Policy (6157)
Tag
Academia (1065)
Allergies (18)
Alliances (10237)
Alzheimer's disease (181)
Approvals (4834)
Artificial intelligence (28)
Bankruptcy (35)
Best Places to Work (2804)
Breast cancer (36)
Cancer (245)
Cardiovascular disease (47)
Career advice (160)
Cell therapy (38)
Clinical research (14013)
Collaboration (85)
COVID-19 (1353)
Data (333)
Diabetes (32)
Diagnostics (1746)
Earnings (10955)
Events (16206)
Executive appointments (69)
FDA (5010)
Funding (68)
Gene therapy (30)
GLP-1 (93)
Government (1289)
Healthcare (6457)
Infectious disease (1382)
Inflammatory bowel disease (29)
IPO (2048)
Job creations (394)
Job search strategy (152)
Layoffs (31)
Legal (939)
Lung cancer (29)
Lymphoma (21)
Manufacturing (21)
Medical device (4642)
Medtech (4643)
Mergers & acquisitions (3099)
Metabolic disorders (57)
Neuroscience (229)
NextGen Class of 2024 (1907)
Non-profit (1570)
Northern California (282)
Obesity (28)
Opinion (21)
Patient recruitment (20)
People (11090)
Phase I (3736)
Phase II (6182)
Phase III (5241)
Pipeline (76)
Postmarket research (739)
Preclinical (1111)
Radiopharmaceuticals (38)
Rare diseases (51)
Real estate (955)
Regulatory (4312)
Research institute (923)
RSV (17)
Southern California (180)
Startups (641)
United States (2518)
Vaccines (214)
Weight loss (18)
Date
Today (20)
Last 7 days (106)
Last 30 days (424)
Last 365 days (6025)
2024 (6001)
2023 (7363)
2022 (13465)
2021 (13992)
2020 (14464)
2019 (11708)
2018 (8672)
2017 (6665)
2016 (6629)
2015 (7492)
2014 (5487)
2013 (4788)
2012 (5171)
2011 (5418)
2010 (4645)
Location
Africa (154)
Arizona (46)
Asia (8552)
Australia (1364)
California (547)
Canada (206)
China (80)
Colorado (46)
Connecticut (26)
Delaware (19)
Europe (17820)
Florida (106)
Georgia (29)
Illinois (114)
Indiana (42)
Kansas (17)
Maryland (87)
Massachusetts (376)
Michigan (23)
Minnesota (54)
New Jersey (215)
New York (162)
North Carolina (185)
Northern California (282)
Ohio (33)
Pennsylvania (128)
South America (239)
Southern California (180)
Tennessee (26)
Texas (87)
Utah (32)
Virginia (22)
Washington State (51)
143,395 Results for "mount sinai hospital".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mount Sinai Medical Center Chief of Orthopedic Surgery Publishes Technique on Minimally Invasive Procedure for Achilles Tendonitis
September 11, 2024
·
2 min read
Press Releases
PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA
October 22, 2024
·
3 min read
Business
A.D.A.M. and the Icahn School of Medicine at Mount Sinai Announce Collaboration to Advance Bone Implant Technology and Healthcare Innovation
Advanced Development of Additive Manufacturing ( A.D.A.M. ), a provider of 3D printing systems for customized bone implants, and the Icahn School of Medicine at Mount Sinai , in New York, NY , a renowned educational and health institution, have established a collaboration, which aims to enhance healthcare by innovating in bone implant delivery and soft tissue medical device development.
January 26, 2024
·
1 min read
Lone Star Bio
HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms
Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence -powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced the closing of its license agreements with the Icahn School of Medicine at Mount Sinai, in New York, NY, to develop and commercialize electrocardiographic AI algorithms and assets.
November 20, 2023
·
5 min read
Lone Star Bio
The Caris Precision Oncology Alliance Welcomes the Icahn School of Medicine at Mount Sinai
Caris Life Sciences® announced that the Icahn School of Medicine at Mount Sinai, in New York, NY, has joined the Caris Precision Oncology Alliance™ and will collaborate with Caris on various research projects.
July 6, 2023
·
4 min read
Biotech Bay
UCSF QBI, University College London, and Mount Sinai Identify Shared Molecular Mechanisms Across SARS-CoV-2 Variants that Allow Virus to Thrive Despite Vaccination
In a study published online in CELL , scientists at UCSF QBI, University College London and the Icahn School of Medicine at Mount Sinai reported breakthrough findings on convergent evolutionary mechanisms shared by COVID-19 variants, allowing them to overcome both adaptive and innate immune system barriers.
September 21, 2023
·
10 min read
Postmarket research
Regeneron, Bayer Build Retinal Vein Occlusion Case for Eylea as Biosimilar Pressure Mounts
The Phase III win could help Regeneron and Bayer expand into retinal vein occlusion, a move that the partners need to help shore up sales of their Eylea franchise amid biosimilar encroachment.
December 17, 2024
·
2 min read
·
Tristan Manalac
GLP-1
Evidence Mounts for Potential of GLP-1s in Alzheimer’s Disease
The darlings of the weight loss and diabetes spaces, GLP-1 receptor agonists have shown promise against Alzheimer’s in recent studies—with Phase III results expected next year from Novo Nordisk.
December 9, 2024
·
6 min read
·
Heather McKenzie
BioMidwest
NovAccess Global Files Patent with Cedars-Sinai to Advance its Brain Cancer Fighting Vaccine Platform
NovAccess Global Inc. announced it has submitted a provisional patent for new intellectual property developed at Cedars-Sinai to advance the Company’s immunotherapy platform.
May 21, 2024
·
3 min read
Mergers & acquisitions
Novo, Catalent $16.5B Deal Wins EU Blessing as US Antitrust Scrutiny Mounts
In the U.S., the chorus of opposition against the proposed buyout continues to grow and now includes the CEOs of Roche and Lilly, a broad coalition of unions and consumer groups and at least one senator.
December 9, 2024
·
2 min read
·
Tristan Manalac
1 of 14,340
Next